A detailed history of Marino, Stram & Associates LLC transactions in Novartis Ag stock. As of the latest transaction made, Marino, Stram & Associates LLC holds 4,442 shares of NVS stock, worth $437,314. This represents 0.11% of its overall portfolio holdings.

Number of Shares
4,442
Previous 4,416 0.59%
Holding current value
$437,314
Previous $470,000 8.51%
% of portfolio
0.11%
Previous 0.12%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$106.13 - $120.89 $2,759 - $3,143
26 Added 0.59%
4,442 $510,000
Q2 2024

Jul 18, 2024

SELL
$92.57 - $107.37 $4,535 - $5,261
-49 Reduced 1.1%
4,416 $470,000
Q3 2023

Oct 30, 2023

SELL
$94.73 - $105.13 $16,483 - $18,292
-174 Reduced 3.75%
4,465 $454,000
Q2 2023

Jul 20, 2023

BUY
$92.52 - $104.91 $185 - $209
2 Added 0.04%
4,639 $468,000
Q1 2023

Apr 20, 2023

BUY
$80.03 - $92.81 $2,480 - $2,877
31 Added 0.67%
4,637 $426,000
Q4 2022

Jan 19, 2023

BUY
$75.55 - $92.52 $3,097 - $3,793
41 Added 0.9%
4,606 $0
Q3 2022

Oct 17, 2022

BUY
$74.61 - $87.26 $4,476 - $5,235
60 Added 1.33%
4,565 $347,000
Q2 2022

Jul 15, 2022

BUY
$80.52 - $93.75 $19,807 - $23,062
246 Added 5.78%
4,505 $381,000
Q1 2022

Apr 25, 2022

BUY
$80.11 - $90.62 $11,375 - $12,868
142 Added 3.45%
4,259 $374,000
Q4 2021

Jan 20, 2022

SELL
$79.7 - $88.13 $39,610 - $43,800
-497 Reduced 10.77%
4,117 $360,000
Q3 2021

Oct 14, 2021

BUY
$81.78 - $95.14 $377,332 - $438,975
4,614 New
4,614 $377,000
Q2 2021

Jul 22, 2021

SELL
$85.24 - $94.15 $418,016 - $461,711
-4,904 Closed
0 $0
Q1 2021

Apr 26, 2021

BUY
$83.5 - $98.47 $250 - $295
3 Added 0.06%
4,904 $419,000
Q4 2020

Jan 19, 2021

BUY
$78.07 - $94.43 $3,981 - $4,815
51 Added 1.05%
4,901 $463,000
Q3 2020

Oct 22, 2020

SELL
$82.14 - $91.0 $24,231 - $26,845
-295 Reduced 5.73%
4,850 $422,000
Q2 2020

Jul 20, 2020

BUY
$80.93 - $91.1 $34,395 - $38,717
425 Added 9.0%
5,145 $449,000
Q1 2020

May 05, 2020

SELL
$70.67 - $99.01 $32,084 - $44,950
-454 Reduced 8.77%
4,720 $389,000
Q4 2019

Jan 31, 2020

SELL
$84.35 - $95.37 $4,639 - $5,245
-55 Reduced 1.05%
5,174 $490,000
Q3 2019

Oct 15, 2019

SELL
$85.54 - $94.26 $1,539 - $1,696
-18 Reduced 0.34%
5,229 $454,000
Q2 2019

Jul 19, 2019

SELL
$75.4 - $92.8 $19,830 - $24,406
-263 Reduced 4.77%
5,247 $479,000
Q1 2019

May 14, 2019

BUY
$75.32 - $86.15 $1,054 - $1,206
14 Added 0.25%
5,510 $530,000
Q4 2018

Feb 14, 2019

BUY
$73.66 - $82.02 $147 - $164
2 Added 0.04%
5,496 $472,000
Q3 2018

Nov 14, 2018

SELL
$66.94 - $77.43 $25,102 - $29,036
-375 Reduced 6.39%
5,494 $473,000
Q2 2018

Aug 14, 2018

SELL
$64.91 - $73.36 $1,038 - $1,173
-16 Reduced 0.27%
5,869 $443,000
Q1 2018

May 15, 2018

BUY
$70.39 - $84.15 $1,759 - $2,103
25 Added 0.43%
5,885 $476,000
Q4 2017

Mar 09, 2018

BUY
$72.33 - $77.64 $423,853 - $454,970
5,860
5,860 $492,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Marino, Stram & Associates LLC Portfolio

Follow Marino, Stram & Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marino, Stram & Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marino, Stram & Associates LLC with notifications on news.